Early research (Phase 1)Study completedNCT00002268
What this trial is testing
A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria
Who this might be right for
Cytomegalovirus InfectionsHIV Infections
Sandoz